BioTime Company Profile (NYSEMKT:BTX)

About BioTime

BioTime logoBioTime, Inc. is a clinical-stage biotechnology company. The Company is focused on the field of regenerative medicine, specifically pluripotent stem cell technology. The Company is engaged in the research and development of therapeutic products for oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer, and hydrogel products that may be used in surgery and products for human embryonic stem cell research. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. The Company's pluripotent stem cell technology is complemented by its HyStem technology for the delivery and engraftment of cells, whether derived from pluripotent stem cells or the patient's own somatic or adult stem cells, at the desired location.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NYSEMKT
  • Symbol: BTX
  • CUSIP: 09066L10
Key Metrics:
  • Previous Close: $3.59
  • 50 Day Moving Average: $3.20
  • 200 Day Moving Average: $2.90
  • 52-Week Range: $101,667,000.00 - $2.02
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.05
  • P/E Growth: 0.00
  • Market Cap: $386.33M
  • Outstanding Shares: 101,667,000
  • Beta: 1.37
Additional Links:
Companies Related to BioTime:

Analyst Ratings

Consensus Ratings for BioTime (NYSEMKT:BTX) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.00

Analysts' Ratings History for BioTime (NYSEMKT:BTX)
Show:
DateFirmActionRatingPrice TargetDetails
9/23/2016Ladenburg ThalmannInitiated CoverageBuy$6.00View Rating Details
4/7/2016Chardan CapitalInitiated CoverageBuyView Rating Details
4/2/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for BioTime (NYSEMKT:BTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q216($0.17)$0.26$1.75 million$1.27 millionViewN/AView Earnings Details
5/10/2016Q116($0.14)($0.19)$1.43 million$2.10 millionViewN/AView Earnings Details
3/9/2016Q4($0.17)($0.16)ViewN/AView Earnings Details
5/11/2015Q115($0.13)$1.10 million$1.30 millionViewN/AView Earnings Details
11/10/2014Q314($0.12)$1.20 millionViewN/AView Earnings Details
8/12/2014Q214($0.16)$362.25 million$300.08 millionViewN/AView Earnings Details
5/12/2014Q114($0.14)$0.61 million$1.07 millionViewN/AView Earnings Details
11/12/2013Q3($0.16)ViewN/AView Earnings Details
3/18/2013Q412($0.12)$1.70 million$1.20 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioTime (NYSEMKT:BTX)
Current Year EPS Consensus Estimate: $-0.26 EPS
Next Year EPS Consensus Estimate: $-0.42 EPS

Dividends

Dividend History for BioTime (NYSEMKT:BTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioTime (NYSEMKT:BTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/21/2016Broadwood Partners LpDirectorBuy2,732,636$2.39$6,531,000.04View SEC Filing  
1/20/2016Broadwood Partners LpDirectorBuy300,000$2.35$705,000.00View SEC Filing  
11/6/2015Alfred D KingsleyInsiderSell100,000$3.83$383,000.00View SEC Filing  
11/6/2015Stephen C FarrellDirectorBuy50,000$3.83$191,500.00View SEC Filing  
8/26/2015Deborah J AndrewsDirectorBuy2,000$2.82$5,640.00View SEC Filing  
8/18/2015Stephen Lahue CarttDirectorBuy75,000$2.80$210,000.00View SEC Filing  
10/8/2014David SchlachetDirectorBuy32,050$3.12$99,996.00View SEC Filing  
7/22/2014Broadwood Partners LpDirectorBuy370,000$2.65$980,500.00View SEC Filing  
7/22/2014Michael D WestCEOSell270,000$2.65$715,500.00View SEC Filing  
7/22/2014Robert PeabodyCFOSell100,000$2.65$265,000.00View SEC Filing  
6/17/2014William P Phd TewInsiderSell30,000$3.07$92,100.00View SEC Filing  
6/16/2014Broadwood Partners LpDirectorBuy1,000,000$2.50$2,500,000.00View SEC Filing  
5/16/2014Broadwood Partners LpDirectorBuy300,000$2.45$735,000.00View SEC Filing  
5/8/2014Broadwood Partners LpDirectorBuy300,000$2.44$732,000.00View SEC Filing  
5/1/2014Broadwood Partners LpDirectorBuy2,000,000$2.52$5,040,000.00View SEC Filing  
2/25/2014Broadwood Partners LpDirectorBuy500,000$3.74$1,870,000.00View SEC Filing  
12/30/2013Neal C BradsherDirectorBuy300,042$3.51$1,053,147.42View SEC Filing  
11/20/2013William P Phd TewInsiderSell13,860$3.76$52,113.60View SEC Filing  
9/12/2013Stephen C FarrellDirectorBuy11,213$3.89$43,618.57View SEC Filing  
8/20/2013Stephen C FarrellDirectorBuy4,187$3.65$15,282.55View SEC Filing  
8/12/2013Eschenbach Andrew C VonDirectorBuy3,000$3.69$11,070.00View SEC Filing  
3/28/2013Broadwood Partners LpDirectorBuy200,000$3.81$762,000.00View SEC Filing  
11/15/2012Broadwood Partners LpDirectorBuy344,828$2.90$1,000,001.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioTime (NYSEMKT:BTX)
DateHeadline
zacks.com logoBioTime (BTX) Shows Strength: Stock Adds 5.9% in Session (NYSEMKT:BTX)
www.zacks.com - September 26 at 8:47 AM
News IconBioTime To Webcast Presentation At The 2016 Healthcare Conference (NYSEMKT:BTX)
www.biospace.com - September 24 at 8:14 AM
benzinga.com logoLadenburg Initiates BioTime Shares With Buy, $6 Price Target (NYSEMKT:BTX)
www.benzinga.com - September 24 at 8:14 AM
benzinga.com logoLadenburg Initiates BioTime Shares With Buy, $6 Price Target - Benzinga (NYSEMKT:BTX)
www.benzinga.com - September 23 at 3:26 PM
finance.yahoo.com logoCoverage initiated on BioTime by Ladenburg Thalmann (NYSEMKT:BTX)
finance.yahoo.com - September 23 at 3:26 PM
finance.yahoo.com logoBioTime to Webcast Presentation at the Ladenburg Thalmann 2016 Healthcare Conference (NYSEMKT:BTX)
finance.yahoo.com - September 23 at 9:07 AM
News IconStocks Within Analyst Limelight: BioTime, Inc. (NYSEMKT:BTX ... - Wall Street Times (press release) (NYSEMKT:BTX)
www.wallstreetnews24.com - September 15 at 4:19 PM
streetinsider.com logoBioTime (BTX) Affirms Announcement of Positive AST-OPC1 SCiSTAR Phase 1/2a Data (AST) - StreetInsider.com (NYSEMKT:BTX)
www.streetinsider.com - September 15 at 4:19 PM
finance.yahoo.com logoBioTime Affiliate, Asterias Biotherapeutics, Announced Positive Interim Efficacy Data From Trial in Patients With Complete Cervical Spinal Cord Injuries (NYSEMKT:BTX)
finance.yahoo.com - September 15 at 4:19 PM
istreetwire.com logoStocks To Track: Reynolds American (RAI), Iron Mountain (IRM), BioTime (BTX) - iStreetWire (NYSEMKT:BTX)
istreetwire.com - September 10 at 3:49 PM
News IconShares Higher in Today's Session: BioTime, Inc. (:BTX) - Post News (NYSEMKT:BTX)
www.kentuckypostnews.com - September 9 at 3:55 PM
News IconStock Showing Gains in Afternoon Trading: BioTime, Inc. (:BTX) - National Daily Press (NYSEMKT:BTX)
www.nationaldailypress.com - September 9 at 3:55 PM
News IconTime To Put On The Watch List? - BioTime, Inc. (NYSEMKT:BTX), Clovis Oncology, Inc. (NASDAQ:CLVS) - The Voice Registrar (NYSEMKT:BTX)
voiceregistrar.com - September 9 at 3:55 PM
capitalcube.com logoETF’s with exposure to BioTime, Inc. : September 9, 2016 (NYSEMKT:BTX)
www.capitalcube.com - September 9 at 3:55 PM
News IconNoteworthy Thursday Option Activity: TLRD, BTX, CEMP (NYSEMKT:BTX)
www.stockoptionschannel.com - September 9 at 8:50 AM
News IconStock Gapping Higher Pre-Market: BioTime, Inc. (:BTX) - Post News (NYSEMKT:BTX)
www.kentuckypostnews.com - September 8 at 3:53 PM
News IconSession Monitor - Active Stock Review on Shares of BioTime, Inc. (:BTX) - Post News (NYSEMKT:BTX)
www.kentuckypostnews.com - September 8 at 3:53 PM
investorplace.com logoBiggest Movers in Manufacturing Stocks Now - HSGX EDGE KTOV DPRX - Investorplace.com (NYSEMKT:BTX)
investorplace.com - September 8 at 6:56 AM
News IconNarrowing the Lens on BioTime, Inc. (:BTX) - Duncan Research (NYSEMKT:BTX)
www.duncanindependent.com - September 8 at 6:56 AM
News IconStock Showing Gains in Today's Session: BioTime, Inc. (:BTX) - Post News (NYSEMKT:BTX)
www.kentuckypostnews.com - September 8 at 6:56 AM
publicnow.com logoAsterias Biotherapeutics Announces Interim Efficacy Data from SCiStar Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury Patients to be Presented at the 55th ISCoS Annual Scientific Meeting (NYSEMKT:BTX)
www.publicnow.com - September 7 at 10:20 AM
finance.yahoo.com logoBioTime to Present at Two Upcoming Investor Conferences - Yahoo Finance (NYSEMKT:BTX)
finance.yahoo.com - September 6 at 3:55 PM
News IconOTC Investors Supremely Interested in Shares of BioTime, Inc. (:BTX) - Duncan Research (NYSEMKT:BTX)
www.duncanindependent.com - September 6 at 3:55 PM
News IconShares Gapping Lower Before the Open: BioTime, Inc. (:BTX) - Post News (NYSEMKT:BTX)
www.kentuckypostnews.com - September 6 at 3:55 PM
kcregister.com logoInvestors Alert: BioTime, Inc. (NYSE:BTX), Charter Communications, Inc. (NASDAQ:CHTR), Gilead Sciences Inc ... - KC Register (NYSEMKT:BTX)
www.kcregister.com - September 3 at 3:48 PM
News IconA Second Look at Shares of BioTime, Inc. (:BTX) - Duncan Research (NYSEMKT:BTX)
www.duncanindependent.com - September 3 at 3:48 PM
kcregister.com logoStocks Swings: Kewaunee Scientific Corp. (NASDAQ:KEQU), BioTime, Inc. (NYSE:BTX), Pepsico, Inc. (NYSE:PEP ... - KC Register (NYSEMKT:BTX)
www.kcregister.com - September 1 at 3:57 PM
News IconTaking a Serious Look at BioTime, Inc. (:BTX) - Duncan Research (NYSEMKT:BTX)
www.duncanindependent.com - September 1 at 3:57 PM
capitalcube.com logoBioTime, Inc. breached its 50 day moving average in a Bullish Manner : BTX-US : August 31, 2016 (NYSEMKT:BTX)
www.capitalcube.com - August 31 at 8:47 AM
News IconZeroing Our Focus on BioTime, Inc. (:BTX) - Duncan Research (NYSEMKT:BTX)
www.duncanindependent.com - August 30 at 11:49 AM
capitalcube.com logoETF’s with exposure to BioTime, Inc. : August 29, 2016 (NYSEMKT:BTX)
www.capitalcube.com - August 29 at 3:22 PM
News IconOTC Investors Keen on Shares of BioTime, Inc. (:BTX) - Duncan Research (NYSEMKT:BTX)
www.duncanindependent.com - August 26 at 3:54 PM
kcregister.com logoStocks to Watch: Cerulean Pharma Inc. (NASDAQ:CERU), BioTime, Inc. (NYSE:BTX), Pfizer Inc. (NYSE:PFE ... - KC Register (NYSEMKT:BTX)
www.kcregister.com - August 23 at 8:08 AM
finance.yahoo.com logoBIOTIME INC Financials (NYSEMKT:BTX)
finance.yahoo.com - August 18 at 4:10 PM
News IconContango ORE, Inc. Announces Recent Drilling Results (NYSEMKT:BTX)
www.onenewspage.com - August 16 at 4:04 PM
finance.yahoo.com logo8:01 am BioTime announces the issuance of 31 new patents (NYSEMKT:BTX)
finance.yahoo.com - August 15 at 11:13 AM
publicnow.com logoBioTime Announces Issuance of 31 New Patents to Strengthen its Patent Portfolio in Regenerative Medicine (NYSEMKT:BTX)
www.publicnow.com - August 15 at 11:13 AM
capitalcube.com logoETF’s with exposure to BioTime, Inc. : August 15, 2016 (NYSEMKT:BTX)
www.capitalcube.com - August 15 at 11:13 AM
capitalcube.com logoBioTime, Inc. :BTX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NYSEMKT:BTX)
www.capitalcube.com - August 12 at 3:28 PM
kcregister.com logoNews Buzz: BioTime, Inc. (NYSE:BTX), Micronet Enertec Technologies, Inc. (NASDAQ:MICT), Evolving Systems ... - KC Register (NYSEMKT:BTX)
www.kcregister.com - August 11 at 4:05 PM
cnbc.com logoBioTime posts 2Q profit (NYSEMKT:BTX)
www.cnbc.com - August 9 at 10:34 PM
biz.yahoo.com logoQ2 2016 BioTime Inc Earnings Release - After Market Close (NYSEMKT:BTX)
biz.yahoo.com - August 9 at 12:55 PM
istreetwire.com logoTrader's Buzzers: Fidelity National Financial, Inc. (FNF), BioTime, Inc. (BTX), Fair Isaac Corporation (FICO) - iStreetWire (NYSEMKT:BTX)
istreetwire.com - July 30 at 2:10 PM
kcregister.com logoToday's Hot List: BioTime, Inc. (NYSE:BTX), Robert Half International (NYSE:RHI), Duke Realty Corporation (NYSE ... - KC Register (NYSEMKT:BTX)
www.kcregister.com - July 28 at 12:44 PM
businesswire.com logoBioTime, Inc. to Report Second Quarter Results on August 9, 2016 ... - Business Wire (press release) (NYSEMKT:BTX)
www.businesswire.com - July 27 at 9:44 PM
finance.yahoo.com logoBioTime, Inc. to Report Second Quarter Results on August … (NYSEMKT:BTX)
finance.yahoo.com - July 27 at 12:32 PM
publicnow.com logoBioTime, Inc. to Report Second Quarter Results on August 9, 2016 (NYSEMKT:BTX)
www.publicnow.com - July 27 at 9:08 AM
news.cmlviz.com logoBioTime Inc (AMEX:BTX) Stock Volatility Hits An Unsually High Level - CML News (NYSEMKT:BTX)
news.cmlviz.com - July 21 at 4:04 PM
capitalcube.com logoETF’s with exposure to BioTime, Inc. : July 21, 2016 (NYSEMKT:BTX)
www.capitalcube.com - July 21 at 1:50 PM
News IconBiotime Incorporated (NYSEMKT:BTX) Shorts Decreased by 26.35% After Short Covering - Consumer Eagle (NYSEMKT:BTX)
www.consumereagle.com - July 20 at 5:03 PM

Social


Last Updated on 9/26/2016 by MarketBeat.com Staff